These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18635234)

  • 1. Medical stone management: 35 years of advances.
    Pak CY
    J Urol; 2008 Sep; 180(3):813-9. PubMed ID: 18635234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of medical approach in the management of stone disease.
    Pak CY
    Int J Urol; 1996 Jan; 3(1 Suppl):S63-6. PubMed ID: 24304028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia.
    Karsli O; Izol V; Aridogan IA; Borekoglu A; Satar N
    Urolithiasis; 2013 Feb; 41(1):9-13. PubMed ID: 23532417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review.
    Castellani D; Giulioni C; De Stefano V; Brocca C; Fuligni D; Galosi AB; Teoh JY; Sarica K; Gauhar V
    World J Urol; 2023 May; 41(5):1243-1250. PubMed ID: 36645461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From hypercalciuria to hypocitraturia--a shifting trend in pediatric urolithiasis?
    Kovacevic L; Wolfe-Christensen C; Edwards L; Sadaps M; Lakshmanan Y
    J Urol; 2012 Oct; 188(4 Suppl):1623-7. PubMed ID: 22910255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.
    Alon US; Zimmerman H; Alon M
    Pediatr Nephrol; 2004 May; 19(5):516-20. PubMed ID: 15015063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of urinary lithiasis].
    Cachat F; Barbey F; Daudon M
    Rev Med Suisse Romande; 2004 Aug; 124(8):461-4. PubMed ID: 15495468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.